Mariko Nagashima
Department of Cardiovascular Research
Berlex Biosciences
Richmond
USA
Name/email consistency: high
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. Nagashima, M., Yin, Z.F., Zhao, L., White, K., Zhu, Y., Lasky, N., Halks-Miller, M., Broze, G.J., Fay, W.P., Morser, J. J. Clin. Invest. (2002)
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice. Nagashima, M., Yin, Z.F., Broze, G.J., Morser, J. Front. Biosci. (2002)
- An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model. Nagashima, M., Werner, M., Wang, M., Zhao, L., Light, D.R., Pagila, R., Morser, J., Verhallen, P. Thromb. Res. (2000)